Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 5/2007

Open Access 01-10-2007 | Research article

Association of the microsatellite in the 3' untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study

Authors: Trinidad Martin-Donaire, Ignacio Losada-Fernandez, Gema Perez-Chacon, Iñigo Rua-Figueroa, Celia Erausquin, Antonio Naranjo-Hernandez, Silvia Rosado, Florentino Sanchez, Ayoze Garcia-Saavedra, Maria Jesus Citores, Juan A Vargas, Paloma Perez-Aciego

Published in: Arthritis Research & Therapy | Issue 5/2007

Login to get access

Abstract

CD40–CD154 interaction is an important mediator of inflammation and has been implicated in T helper type 1-mediated autoimmune diseases including rheumatoid arthritis (RA). Linkage studies have shown association of markers in the proximity of the CD154 gene. In the present work we investigated whether specific allele variants of the microsatellite in the 3' UTR of the CD154 gene might modulate the risk of RA. The study, in a case-control setting, included 189 patients and 150 healthy controls from the Canary Islands, Spain. The 24CAs allele was less represented in female patients than in controls (0.444 in controls versus 0.307 in patients, P = 0.006, odds ratio (OR) 0.556, 95% confidence interval (CI) 0.372 to 0.831) but not in males (0.414 versus 0.408), and only when homozygous (P = 0.012; OR 0.35, 95% CI 0.16 to 0.77). We also verified that CD154 association with RA was independent of human leukocyte antigen (HLA) phenotype. A further functional study showed that after stimulation anti-CD3, CD154 mRNA was more stable in CD4+ T lymphocytes from patients with RA bearing the 24CAs allele (mRNA half-life 208 minutes) than in patients without the 24CAs allele (109 minutes, P = 0.009). However, a lower percentage of CD154+CD4+ T lymphocytes was seen in freshly isolated peripheral blood mononuclear cells from patients carrying 24CAs alleles (mean 4.28 versus 8.12; P = 0.033), and also in CD4+ T lymphocytes stimulated with anti-CD3 (median 29.40 versus 47.60; P = 0.025). These results were concordant with the smaller amounts of CD154 mRNA isolated from stimulated T lymphocytes with 24CAs alleles. The CD154 microsatellite therefore seems to affect the expression of the gene in a complex manner that implies not only mRNA stability. These data suggest that the CD154 microsatellite contributes to the regulation of mRNA and protein expression, although further studies will be necessary to elucidate its role in disease predisposition.
Appendix
Available only for authorised users
Literature
1.
Decker JL, Malone DG, Haraoui B, Wahl SM, Schrieber L, Klippel JH, Steinberg AD, Wilder RL: NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med. 1984, 101: 810-824.CrossRefPubMed
2.
3.
Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS: Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002, 61: 290-297. 10.1136/ard.61.4.290.PubMedCentralCrossRefPubMed
4.
Wassmuth R, Wagner U: Prognostic use of human leukocyte antigen genotyping for rheumatoid arthritis susceptibility, disease course, and clinical stratification. Rheum Dis Clin North Am. 2002, 28: 17-37. 10.1016/S0889-857X(03)00067-X.CrossRefPubMed
5.
van der Helm-van Mil AH, Wesoly JZ, Huizinga TW: Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol. 2005, 17: 299-304. 10.1097/01.bor.0000160780.13012.be.CrossRefPubMed
6.
MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43: 30-37. 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.CrossRefPubMed
7.
Dieude P, Cornelis F: Genetic basis of rheumatoid arthritis. Joint Bone Spine. 2005, 72: 520-526. 10.1016/j.jbspin.2005.09.001.CrossRefPubMed
8.
9.
Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A: New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA. 1998, 95: 10746-10750. 10.1073/pnas.95.18.10746.PubMedCentralCrossRefPubMed
10.
Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, et al: A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet. 2001, 68: 927-936. 10.1086/319518.PubMedCentralCrossRefPubMed
11.
Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, Panayi GS, Lewis CM, Lanchbury JS: Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum. 2000, 43: 1673-1678. 10.1002/1529-0131(200008)43:8<1673::AID-ANR2>3.0.CO;2-Y.CrossRefPubMed
12.
MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S, et al: Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 2002, 46: 632-639. 10.1002/art.10147.CrossRefPubMed
13.
John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W, Vasavda N, Mills T, Barton A, Hinks A, et al: Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet. 2004, 75: 54-64. 10.1086/422195.PubMedCentralCrossRefPubMed
14.
Etzel CJ, Chen WV, Shepard N, Jawaheer D, Cornelis F, Seldin MF, Gregersen PK, Amos CI: Genome-wide meta-analysis for rheumatoid arthritis. Hum Genet. 2006, 119: 634-641. 10.1007/s00439-006-0171-8.CrossRefPubMed
15.
Choi SJ, Rho YH, Ji JD, Song GG, Lee YH: Genome scan meta-analysis of rheumatoid arthritis. Rheumatology. 2006, 45: 166-170. 10.1093/rheumatology/kei128.CrossRefPubMed
16.
Aarvak T, Natvig JB: Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res. 2001, 3: 13-17. 10.1186/ar135.PubMedCentralCrossRefPubMed
17.
Rissoan MC, van KC, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, Miossec P, Banchereau J: The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol. 1996, 106: 481-490. 10.1046/j.1365-2249.1996.d01-858.x.PubMedCentralCrossRefPubMed
18.
Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS, Park SH, Choe J, Kim HY: CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. J Immunol. 2000, 164: 5055-5061.CrossRefPubMed
19.
Harigai M, Hara M, Nakazawa S, Fukasawa C, Ohta S, Sugiura T, Inoue K, Kashiwazaki S: Ligation of CD40 induced tumor necrosis factor-α in rheumatoid arthritis: a novel mechanism of activation of synoviocytes. J Rheumatol. 1999, 26: 1035-1043.PubMed
20.
Mottonen M, Isomaki P, Luukkainen R, Lassila O: Regulation of CD154-induced interleukin-12 production in synovial fluid macrophages. Arthritis Res. 2002, 4: R9-10.1186/ar589.PubMedCentralCrossRefPubMed
21.
MacDonald KP, Nishioka Y, Lipsky PE, Thomas R: Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest. 1997, 100: 2404-2414.PubMedCentralCrossRefPubMed
22.
Gotoh H, Kawaguchi Y, Harigai M, Hara M, Saito S, Yamaguchi T, Shimada K, Kawamoto M, Tomatsu T, Kamatani N: Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases. J Rheumatol. 2004, 31: 1506-1512.PubMed
23.
Berner B, Wolf G, Hummel KM, Muller GA, Reuss-Borst MA: Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis. 2000, 59: 190-195. 10.1136/ard.59.3.190.PubMedCentralCrossRefPubMed
24.
Liu MF, Chao SC, Wang CR, Lei HY: Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity. 2001, 34: 107-113.CrossRefPubMed
25.
Gaur U, Aggarwal BB: Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003, 66: 1403-1408. 10.1016/S0006-2952(03)00490-8.CrossRefPubMed
26.
Srahna M, Remacle JE, Annamalai K, Pype S, Huylebroeck D, Boogaerts MA, Vandenberghe P: NF-κB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells. Clin Exp Immunol. 2001, 125: 229-236. 10.1046/j.1365-2249.2001.01601.x.PubMedCentralCrossRefPubMed
27.
Tsytsykova AV, Tsitsikov EN, Geha RS: The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem. 1996, 271: 3763-3770. 10.1074/jbc.271.7.3763.CrossRefPubMed
28.
Schubert LA, Cron RQ, Cleary AM, Brunner M, Song A, Lu LS, Jullien P, Krensky AM, Lewis DB: A T cell-specific enhancer of the human CD40 ligand gene. J Biol Chem. 2002, 277: 7386-7395. 10.1074/jbc.M110350200.CrossRefPubMed
29.
Barnhart B, Kosinski PA, Wang Z, Ford GS, Kiledjian M, Covey LR: Identification of a complex that binds to the CD154 3' untranslated region: implications for a role in message stability during T cell activation. J Immunol. 2000, 165: 4478-4486.CrossRefPubMed
30.
Hamilton BJ, Genin A, Cron RQ, Rigby WF: Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol Cell Biol. 2003, 23: 510-525. 10.1128/MCB.23.2.510-525.2003.PubMedCentralCrossRefPubMed
31.
Singh K, Laughlin J, Kosinski PA, Covey LR: Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J Immunol. 2004, 173: 976-985.CrossRefPubMed
32.
Kosinski PA, Laughlin J, Singh K, Covey LR: A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J Immunol. 2003, 170: 979-988.CrossRefPubMed
33.
Gomolka M, Menninger H, Saal JE, Lemmel EM, Albert ED, Niwa O, Epplen JT, Epplen C: Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients. J Mol Med. 1995, 73: 19-29. 10.1007/BF00203615.CrossRefPubMed
34.
Citores MJ, Perez-Aciego P, Rodriguez-Gallego C, Contreras-Martin B, Garcia-Laorden I, Durantez A: CD154 polymorphism in Spanish populations. Differences in the allelic distribution between Canary islanders and Peninsulars. Eur J Immunogenet. 2000, 27: 141-144. 10.1046/j.1365-2370.2000.00220.x.CrossRefPubMed
35.
Citores MJ, Rua-Figueroa I, Rodriguez-Gallego C, Durantez A, Garcia-Laorden MI, Rodriguez-Lozano C, Rodriguez-Perez JC, Vargas JA, Perez-Aciego : The dinucleotide repeat polymorphism in the 3' UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis. 2004, 63: 310-317. 10.1136/ard.2003.006148.PubMedCentralCrossRefPubMed
36.
Dai Y, Masterman T, Huang W, Hillert J: Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis. Eur J Immunogenet. 2002, 29: 81-85. 10.1046/j.1365-2370.2002.00270.x.CrossRefPubMed
37.
38.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159. 10.1016/0003-2697(87)90021-2.CrossRefPubMed
39.
Schneider S: RDaEL. A Software for Population Genetics Data Analysis. Arlequin ver.2.000. Geneva: Genetics and Biometry Laboratory, University of Geneva
40.
Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, Nuñez-Roldan A, Sanchez B: Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 1993, 36: 811-814. 10.1002/art.1780360611.CrossRefPubMed
41.
Balsa A, Minaur NJ, Pascual-Salcedo D, McCabe C, Balas A, Fiddament B, Vicario JL, Cox NL, Martin-Mola E, Hall ND: Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain). Rheumatology. 2000, 39: 844-849. 10.1093/rheumatology/39.8.844.CrossRefPubMed
42.
MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A: HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol. 1995, 22: 1032-1036.PubMed
43.
Hajeer A, John S, Ollier WE, Silman AJ, Dawes P, Hassell A, Mattey D, Fryer A, Strange R, Worthington J: Tumor necrosis factor microsatellite haplotypes are different in male and female patients with RA. J Rheumatol. 1997, 24: 217-219.PubMed
44.
Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Nunez-Roldan A: Complex associations between HLA-DRB1 genes and female rheumatoid arthritis: results from a prospective study. Hum Immunol. 1999, 60: 1259-1265. 10.1016/S0198-8859(99)00119-6.CrossRefPubMed
45.
de VN, Tak PP, Tijssen H, van Riel PL, van de Putte LB: Female sex increases risk for rheumatoid arthritis only in individuals encoding low-risk HLA-DRB1 alleles. Arthritis Rheum. 2003, 48: 1762-1763. 10.1002/art.11022.CrossRef
46.
Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H, Wagner U: Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther. 2006, 8: R75-10.1186/ar1945.PubMedCentralCrossRefPubMed
47.
Weyand CM, Schmidt D, Wagner U, Goronzy JJ: The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998, 41: 817-822. 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S.CrossRefPubMed
48.
Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI: Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol. 2001, 28: 2644-2649.PubMed
49.
Chavez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sanchez L, Jara LJ, Zenteno E, Blanco-Favela F: Prolactine effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol. 2005, 23: 769-777.PubMed
50.
Lee JH, Jeon MH, Seo YJ, Lee YJ, Ko JH, Tsujimoto Y, Lee JH: CA repeats in the 3'-untranslated region of bcl-2 mRNA mediate constitutive decay of bcl-2 mRNA. J Biol Chem. 2004, 279: 42758-42764. 10.1074/jbc.M407357200.CrossRefPubMed
51.
Khashnobish A, Hamann A, Osiewacz HD: Modulation of gene expression by (CA)n microsatellites in the filamentous ascomycete Podospora anserina. Appl Microbiol Biotechnol. 1999, 52: 191-195. 10.1007/s002530051508.CrossRefPubMed
52.
Martin-Farmer J, Janssen GR: A downstream CA repeat sequence increases translation from leadered and unleadered mRNA in Escherichia coli. Mol Microbiol. 1999, 31: 1025-1038. 10.1046/j.1365-2958.1999.01228.x.CrossRefPubMed
53.
54.
Ford GS, Barnhart B, Shone S, Covey LR: Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol. 1999, 162: 4037-4044.PubMed
55.
Anaya JM, Gomez L, Castiblanco J: Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol. 2006, 13: 185-195. 10.1080/17402520600876762.PubMedCentralCrossRefPubMed
56.
Becker KG: The common genetic hypothesis of autoimmune/inflammatory disease. Curr Opin Allergy Clin Immunol. 2001, 1: 399-405.CrossRefPubMed
Metadata
Title
Association of the microsatellite in the 3' untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study
Authors
Trinidad Martin-Donaire
Ignacio Losada-Fernandez
Gema Perez-Chacon
Iñigo Rua-Figueroa
Celia Erausquin
Antonio Naranjo-Hernandez
Silvia Rosado
Florentino Sanchez
Ayoze Garcia-Saavedra
Maria Jesus Citores
Juan A Vargas
Paloma Perez-Aciego
Publication date
01-10-2007
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2288

Other articles of this Issue 5/2007

Arthritis Research & Therapy 5/2007 Go to the issue

Research article

Spectrocolorimetric assessment of cartilage plugs after autologous osteochondral grafting: correlations between color indices and histological findings in a rabbit model

Research article

The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice

Research article

Insights into spatial configuration of a galactosylated epitope required to trigger arthritogenic T-cell receptors specific for the sugar moiety

Research article

Quantitative gait analysis as a method to assess mechanical hyperalgesia modulated by disease-modifying antirheumatoid drugs in the adjuvant-induced arthritic rat

Research article

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse

Letter

Is fibromyalgia a cardiovascular disease? A comment on Martinez-Lavin's review 'Stress, the stress response system, and fibromyalgia'
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits